» Articles » PMID: 11555628

Neurodevelopmental Delay, Motor Abnormalities and Cognitive Deficits in Transgenic Mice Overexpressing Dyrk1A (minibrain), a Murine Model of Down's Syndrome

Overview
Journal Hum Mol Genet
Date 2001 Sep 14
PMID 11555628
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

Down's syndrome (DS) is a major cause of mental retardation, hypotonia and delayed development. Murine models of DS carrying large murine or human genomic fragments show motor alterations and memory deficits. The specific genes responsible for these phenotypic alterations have not yet been defined. DYRK1A, the human homolog of the Drosophila minibrain gene, maps to the DS critical region of human chromosome 21 and is overexpressed in DS fetal brain. DYRK1A encodes a serine-threonine kinase, probably involved in neuroblast proliferation. Mutant Drosophila minibrain flies have a reduction in both optic lobes and central brain, showing learning deficits and hypoactivity. We have generated transgenic mice (TgDyrk1A) overexpressing the full-length cDNA of Dyrk1A. TgDyrk1A mice exhibit delayed cranio-caudal maturation with functional consequences in neuromotor development. TgDyrk1A mice also show altered motor skill acquisition and hyperactivity, which is maintained to adulthood. In the Morris water maze, TgDyrk1A mice show a significant impairment in spatial learning and cognitive flexibility, indicative of hippocampal and prefrontal cortex dysfunction. In the more complex repeated reversal learning paradigm, this defect turned out to be specifically related to reference memory, whereas working memory was almost unimpaired. These alterations are comparable with those found in the partial trisomy chromosome 16 murine models of DS and suggest a causative role of DYRK1A in mental retardation and in motor anomalies of DS.

Citing Articles

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.

Dohl J, Treadwell Z, Norris C, Head E Alzheimers Dement. 2025; 21(3):e70034.

PMID: 40042516 PMC: 11881635. DOI: 10.1002/alz.70034.


Research advances in huntingtin-associated protein 1 and its application prospects in diseases.

Wu Y, Wang Y, Lu Y, Yan J, Zhao H, Yang R Front Neurosci. 2024; 18:1402996.

PMID: 38975245 PMC: 11224548. DOI: 10.3389/fnins.2024.1402996.


Modeling the impact of neuromorphological alterations in Down syndrome on fast neural oscillations.

Clusella P, Manubens-Gil L, Garcia-Ojalvo J, Dierssen M PLoS Comput Biol. 2024; 20(7):e1012259.

PMID: 38968294 PMC: 11253980. DOI: 10.1371/journal.pcbi.1012259.


Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine.

Kadyan P, Singh L Pharmacol Rep. 2024; 76(4):665-678.

PMID: 38758470 DOI: 10.1007/s43440-024-00602-8.


Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach.

Haut F, Argyrousi E, Arancio O Int J Mol Sci. 2024; 25(1).

PMID: 38203429 PMC: 10779219. DOI: 10.3390/ijms25010259.